How do freeze‑thaw cycles affect serum measurement of glial fibrillary acidic protein (GFAP)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: July 2, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Freeze-Thaw Effects on Serum GFAP Measurement

Serum GFAP demonstrates good stability through up to 3 freeze-thaw cycles with less than 20% variation, but you should limit cycles to a maximum of 3 (preferably 2 or fewer) and always aliquot samples immediately after processing to avoid repeated thawing.

Key Stability Data

The most recent validation study 1 specifically tested serum GFAP stability and found less than 20% variation in samples exposed to up to 5 freeze-thaw cycles, demonstrating robust preanalytical stability. Another study 2 showed a mean change of only 10.4% (95% CI: 9.5-11.4%) after 3 freeze-thaw cycles, confirming acceptable stability within this range.

Practical Guidelines for GFAP Sample Handling

Immediate Processing Requirements

  • Aliquot samples into small volumes (100-200 μL recommended) immediately after centrifugation to prevent the need for repeated freeze-thaw cycles 3, 4
  • Use polypropylene tubes with O-ring sealed screw caps to minimize protein adherence and prevent evaporation 4
  • Process blood within ≤2 hours from collection to freezer (stick-to-freezer time) 3

Storage Recommendations

  • Long-term storage: -80°C or liquid nitrogen (not -20°C) 4
  • Short-term storage (up to 3 months): -20°C is acceptable but suboptimal 5
  • Avoid slow freezing - freeze samples rapidly at -80°C 5

Maximum Freeze-Thaw Cycles

Limit to 3 cycles maximum, preferably 2 or fewer 3, 4. While GFAP shows better stability than some other protein biomarkers, the guidelines consistently emphasize minimizing freeze-thaw exposure.

Critical Distinction: Serum vs. Plasma

Important caveat: Serum biomarkers may be more sensitive to freeze-thaw cycles than plasma biomarkers 4. The 2024 Alzheimer blood biomarker guidelines specifically note that while plasma AD biomarkers remain stable for at least 3 freeze-thaw cycles, serum biomarkers (including Aβ40 and Aβ42) showed significant decreases even after a single freeze-thaw cycle 4. Although GFAP-specific data shows better stability, this general principle suggests extra caution with serum samples.

Documentation Requirements

Always document and standardize 3, 6:

  • Number of freeze-thaw cycles for each sample
  • Storage temperature and duration
  • Time between centrifugation and freezing
  • Type of storage tubes used

This documentation is essential because even small variations can introduce bias when comparing samples across different time points or studies.

Practical Algorithm for Sample Management

  1. At collection: Draw blood into appropriate tubes
  2. Within 2 hours: Centrifuge and separate serum
  3. Immediately after centrifugation: Aliquot into multiple small-volume polypropylene tubes (100-200 μL each)
  4. Freeze rapidly: Place directly into -80°C freezer
  5. For analysis: Thaw only the specific aliquot needed
  6. Never refreeze: Discard any remaining sample after thawing
  7. Track meticulously: Record every freeze-thaw cycle in your database

Common Pitfalls to Avoid

  • Don't pool samples after thawing - this defeats the purpose of aliquoting
  • Don't use -20°C for long-term storage - protein degradation accelerates over time
  • Don't assume all protein biomarkers behave identically - GFAP is relatively stable, but other markers may not be
  • Don't forget to vent headspace if storing on dry ice for shipment, or allow 9 hours at -70°C/-80°C before thawing 3

The evidence demonstrates that GFAP is more robust to freeze-thaw cycles than many other neurological biomarkers, but proper sample handling remains critical for reliable measurements.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.